54 sonuç · Sayfa 1 / 3
WoS
Q2
★ Oto
SCI-Expanded Hakemli
How reliable is 12 core prostate biopsy procedure in the detection of prostate cancer
Canadian Urological Association Journal · 2013 · Cilt 6 · Sayı 2
WoS
Q2
★ Oto
SCI-Expanded Hakemli
Recurrent SKIL activating rearrangements in ETS negative prostate cancer
Oncotarget · 2015 · Cilt 6 · Sayı 8
Scopus WoS
Q2
★ Oto
SCI-Expanded 🌍 Uluslararası Hakemli
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
Cancer Biomarkers · 2015 · Cilt 15 · Sayı 3 · HOLLANDA
Scopus WoS
Q2
★ Oto
SCI-Expanded Hakemli
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
Cancer Biomarkers · 2015 · Cilt 15 · Sayı 3
Scopus WoS Q4
SCI-Expanded Hakemli
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
Cancer Biomarkers · 2015 · Cilt 15 · Sayı 3
Scopus WoS Açık Erişim Q3
SCI-Expanded Hakemli
Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis
CURRENT PROBLEMS IN CANCER · 2025 · Cilt 59
Scopus Açık Erişim
Q4
★ Oto
TR DİZİN Hakemli
Comparison of Post Biopsy Pathology and Post Radical Prostatectomy Pathology in Patients with Prostate Cancer Detected After Fusion Biopsy
Genel Tıp Dergisi · 2023 · Cilt 33 · Sayı 5
prostate cancer
mp-MRG
fusion biopsy
ISUP grade
Scopus Açık Erişim
Q4
★ Oto
TR DİZİN Hakemli
Comparison of Post Biopsy Pathology and Post Radical Prostatectomy Pathology in Patients with Prostate Cancer Detected After Fusion Biopsy
Genel Tıp Dergisi · 2023 · Cilt 33 · Sayı 5
prostate cancer
fusion biopsy
ISUP grade
mp-MRG
WoS
Q1
★ Oto
SCI-Expanded Hakemli
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG Regulated Long Noncoding RNA in Prostate Cancer
Cancer Research · 2015 · Cilt 75 · Sayı 19
Scopus Açık Erişim
Q4
★ Oto
TR DİZİN Hakemli
Comparison of Post Biopsy Pathology and Post Radical Prostatectomy Pathology in Patients with Prostate Cancer Detected After Fusion Biopsy
Genel Tıp Dergisi · 2023 · Cilt 33 · Sayı 5
Scopus WoS
Q2
★ Oto
SCI-Expanded Hakemli
Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells
Urology · 2010 · Cilt 75 · Sayı 4
Q2
★ Oto
SCI Hakemli
- Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells
UROLOGY · 2010
Scopus WoS Açık Erişim Q3
SCI-Expanded Hakemli
Texture analysis of multiparametric magnetic resonance imaging for differentiating clinically significant prostate cancer in the peripheral zone
Turkish Journal Of Medical Sciences · 2023 · Cilt 53 · Sayı 3
Prostate cancer
texture analysis
magnetic resonance imaging
radiomics
Scopus WoS Açık Erişim Q3
SCI-Expanded Hakemli
Texture analysis of multiparametric magnetic resonance imaging for differentiating clinically significant prostate cancer in the peripheral zone
Turkish Journal of Medical Sciences · 2023 · Cilt 53 · Sayı 3
Prostate cancer
texture analysis
magnetic resonance imaging
radiomics
Scopus WoS Q3
SCI-Expanded Hakemli
Physical activity, fatigue, kinesiophobia and quality of life: comparative study of prostate cancer survivors with healthy controls
BMJ Supportive & Palliative Care · 2025 · Cilt 15 · Sayı 2
Scopus WoS Q2
SCI-Expanded Hakemli
Dosimetric correlation of integral dose-dependent lymphopenia in bone marrow after pelvic radiotherapy in locally advanced prostate cancer
International Journal of Radiation Biology · 2026
Scopus WoS Q3
SCI-Expanded Hakemli
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study
Strahlentherapie und Onkologie · 2025
Scopus WoS Açık Erişim
Q3
★ Oto
SCI-Expanded Hakemli
Texture analysis of multiparametric magnetic resonance imaging for differentiating clinically significant prostate cancer in the peripheral zone
The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM)… · 2023 · Cilt 53 · Sayı 3
Scopus Açık Erişim
Q4
★ Oto
TR DİZİN Hakemli
Comparison of Diagnostic Performance of PI-RADS V2 and V2.1 and Interobserver Agreement in Both Versions
Genel Tıp Dergisi · 2024 · Cilt 34 · Sayı 2
PI-RADS V2.1
clinically significant prostate cancer
interobserver agreement